CAH241108P93000
- 0.00
- 0.000.00%
Cardinal Health Newsroom
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $124 to $139
Cardinal Health Is Maintained at Overweight by Barclays
Cardinal Health Analyst Ratings
Cardinal Health's Strong Pharmaceutical Growth and Strategic Moves Justify Buy Rating
Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $133
TD Cowen Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $130
UBS Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $134
Cardinal Health Is Maintained at Buy by UBS
Cardinal Health Analyst Ratings
Nephron Research Adjusts Price Target on Cardinal Health to $130 From $122
Evercore Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $125
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Cardinal Health (CAH) and Sanofi (OtherSNYNF)
Deutsche Bank Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $119
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $140
Evercore Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $125
TD Cowen Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $116
Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $117
Barclays Reaffirms Their Buy Rating on Cardinal Health (CAH)
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Maintains Target Price $101
Sell Rating on Cardinal Health Amid Acquisition Uncertainty and Competitive Concerns